![JPM | Free Full-Text | Evidence to Support Inclusion of Pharmacogenetic Biomarkers in Randomised Controlled Trials JPM | Free Full-Text | Evidence to Support Inclusion of Pharmacogenetic Biomarkers in Randomised Controlled Trials](https://www.mdpi.com/jpm/jpm-09-00042/article_deploy/html/images/jpm-09-00042-g001.png)
JPM | Free Full-Text | Evidence to Support Inclusion of Pharmacogenetic Biomarkers in Randomised Controlled Trials
![A phase 3 trial evaluating panitumumab plus best supportive care vs best supportive care in chemorefractory wild-type KRAS or RAS metastatic colorectal cancer | British Journal of Cancer A phase 3 trial evaluating panitumumab plus best supportive care vs best supportive care in chemorefractory wild-type KRAS or RAS metastatic colorectal cancer | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fbjc.2016.309/MediaObjects/41416_2016_Article_BFbjc2016309_Fig1_HTML.jpg)
A phase 3 trial evaluating panitumumab plus best supportive care vs best supportive care in chemorefractory wild-type KRAS or RAS metastatic colorectal cancer | British Journal of Cancer
![Nurses Flowchart selection and SALOMON level determination as compared... | Download Scientific Diagram Nurses Flowchart selection and SALOMON level determination as compared... | Download Scientific Diagram](https://www.researchgate.net/publication/332743146/figure/fig1/AS:753222855712769@1556593731393/Nurses-Flowchart-selection-and-SALOMON-level-determination-as-compared-with-reference-at.jpg)